News Releases

BHR Biosynex to Showcase Point-of-Care Diagnostics at Best Practice & Women’s Health Professional Care 2026

BHR Biosynex to Showcase Point-of-Care Diagnostics at Best Practice & Women’s Health Professional Care 2026

BHR Biosynex will exhibit at Best Practice London & Women’s Health Professional Care 2026 (Stand J19) at Olympia London on 25–26 February 2026, showcasing a comprehensive portfolio of point-of-care diagnostics and self-tests for GP surgeries, private and women’s specialist clinics, and appropriate home use. Visitors can explore rapid solutions across cardiovascular risk, diabetes, infection, women’s health and biochemistry, designed to move testing closer to the patient, streamline pathways and support faster, more confident clinical decision-making, all backed by robust quality assurance and dedicated after-sales support.

Introducing Point of Care Testing to GP Surgeries

Introducing Point of Care Testing to GP Surgeries

The GP TRIO POCT Pᴀᴄᴋᴀɢᴇ enables a range of clinically valuable test results for monitoring purposes, or diagnostics purposes when taken into consideration with other biochemical tests and physical examination, in under 5 minutes and includes the ultra-portable 𝗟𝗮𝗯𝗣𝗮𝗱® 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 with CRP, D-Dimer and INR assays, hand-held 𝗖𝗮𝗿𝗱𝗶𝗼𝗖𝗵𝗲𝗸® 𝗣𝗔 𝗼𝗿 𝗣𝗹𝘂𝘀 for lipid and glucose testing and portable 𝗤𝘂𝗼-𝗧𝗲𝘀𝘁® for quantitative HbA1c testing.